30 results
PRER14A
BXRXQ
Baudax Bio, Inc.
25 Aug 23
Preliminary revised proxy
4:01pm
to the closing of the Acquisition and approved by the Nominating and Corporate Governance
Committee of the Company’s Board of Directors shall be appointed … of the pharmaceutical industry,
Notice of Special Meeting of Shareholders and Proxy Statement |
her corporate governance experience as a board member
DEFA14A
BXRXQ
Baudax Bio, Inc.
5 Jul 23
Additional proxy soliciting materials
5:28pm
set forth on Exhibit D and approved by the Nominating and Corporate Governance Committee of the Parent Board (each, an “Additional Company Board
8-K
EX-2.1
BXRXQ
Baudax Bio, Inc.
5 Jul 23
Entry into a Material Definitive Agreement
5:26pm
set forth on Exhibit D and approved by the Nominating and Corporate Governance Committee of the Parent Board (each, an “Additional Company Board
424B3
4qbjn0yn
28 Apr 23
Prospectus supplement
4:02pm
8-K
EX-10.2
jvcu3d3ypd 7jiei34
31 Mar 23
Entry into a Material Definitive Agreement
4:50pm
DEFA14A
qui3a8v
1 Jul 21
Additional proxy soliciting materials
7:15am
DEFA14A
60e 1es5498yxu13d2
30 Jun 21
Additional proxy soliciting materials
7:15am
DEFA14A
wrplzgahayfuw qm
13 May 21
Additional proxy soliciting materials
7:30am
DEFA14A
9q1a6
12 May 21
Additional proxy soliciting materials
9:11am
PRE 14A
zwhxa4ywsg306mk4id3
1 Mar 21
Preliminary proxy
5:29pm
8-K
EX-10.1
d5gi5x0 w48z5
22 Jan 21
Entry into a Material Definitive Agreement
5:26pm